<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03699891</url>
  </required_header>
  <id_info>
    <org_study_id>CL1103</org_study_id>
    <nct_id>NCT03699891</nct_id>
  </id_info>
  <brief_title>Evaluation of the Fortilink IBF System With TETRAfuse Technology</brief_title>
  <acronym>ENTRUST</acronym>
  <official_title>Evaluation of the Fortilink IBF System With TETRAfuse Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RTI Surgical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RTI Surgical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, post-market, retrospective study to collect safety and performance
      data for patients implanted with the Fortilink IBF System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, post-market, retrospective study to collect safety and performance
      data for patients implanted with the Fortilink IBF System.

      The study will include up to 110 patients at up to 8 US sites. All patients implanted with
      the Fortilink System at a site will be included in the data collection. The goal is to
      collect data for at least 100 subjects, but the sample size will be capped at 110 to ensure
      that all patients at a given site are included in the analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2018</start_date>
  <completion_date type="Actual">January 15, 2019</completion_date>
  <primary_completion_date type="Actual">January 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety outcomes associated with use of the Fortlink System</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Safety assessment includes evaluation of all adverse events or complications related to the procedure and post-operative adverse events.</description>
  </primary_outcome>
  <enrollment type="Actual">119</enrollment>
  <condition>Cervical and Lumbar Fusion</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fortilink IBF System with TETRAfuse Technology</intervention_name>
    <description>Cervical and lumbar fusion</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient must have had an attempted implant of the Fortilink IBF System
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must have had an attempted implant of the Fortilink IBF System

        Exclusion Criteria:

          -  There are no exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Los Angeles Orthopedic Institute</name>
      <address>
        <city>Sherman Oaks</city>
        <state>California</state>
        <zip>91403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Spine</name>
      <address>
        <city>Lone Tree</city>
        <state>Colorado</state>
        <zip>80124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Back Institute</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33496</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Institute of South Florida</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OrthoBethesda</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 5, 2018</study_first_submitted>
  <study_first_submitted_qc>October 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

